We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $83.3B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
-3.91%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$59.5B
AUM Growth
-$6.44B
Cap. Flow
-$1.84B
Cap. Flow %
-3.1%
Top 10 Hldgs %
21.6%
Holding
1,631
New
128
Increased
589
Reduced
587
Closed
165

Top Buys

Rank Stock Value
1
TRI icon
Thomson Reuters
TRI
+$119M
2
ENB icon
Enbridge
ENB
+$97.8M
3
ORCL icon
Oracle
ORCL
+$95.5M
4
AAPL icon
Apple
AAPL
+$86M
5
GIB icon
CGI
GIB
+$82.4M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$313M
2
COST icon
Costco
COST
+$123M
3
BN icon
Brookfield
BN
+$114M
4
ON icon
ON Semiconductor
ON
+$110M
5
CP icon
Canadian Pacific Kansas City
CP
+$110M

Sector Composition

Rank Sector Weight
1 Financials 20.1%
2 Technology 19.75%
3 Industrials 12.94%
4 Healthcare 9.73%
5 Energy 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MVIS icon
1451
Microvision
MVIS
$6.21M
$22.8K ﹤0.01%
10,917
– –
SPRO icon
1452
Spero Therapeutics
SPRO
$67.7M
$20.1K ﹤0.01%
17,198
– –
CTMX icon
1453
CytomX Therapeutics
CTMX
$675M
$19.4K ﹤0.01%
+15,637
New +$24.6K
MVST icon
1454
Microvast
MVST
$269M
$18.8K ﹤0.01%
10,990
– –
AGEN
1455
Agenus
AGEN
$312M
$18.2K ﹤0.01%
884
-1,048
-54% -$29.7K
AKBA icon
1456
Akebia Therapeutics
AKBA
$354M
$17.7K ﹤0.01%
16,829
-10,370
-38% -$13.3K
SHCR
1457
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$17.1K ﹤0.01%
18,951
– –
CERS icon
1458
Cerus
CERS
$433M
$16.9K ﹤0.01%
11,361
– –
AMWL icon
1459
American Well
AMWL
$180M
$16.9K ﹤0.01%
752
– –
LYEL icon
1460
Lyell Immunopharma
LYEL
$317M
$16.1K ﹤0.01%
560
– –
GEVO icon
1461
Gevo
GEVO
$360M
$14.3K ﹤0.01%
13,034
– –
ME
1462
DELISTED
23andMe Holding Co
ME
$10.7K ﹤0.01%
589
– –
NVTA
1463
DELISTED
Invitae Corporation
NVTA
$10.3K ﹤0.01%
15,402
– –
ONCT
1464
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$5.99K ﹤0.01%
997
– –
BHIL
1465
DELISTED
Benson Hill, Inc.
BHIL
$3.69K ﹤0.01%
334
– –
CANO
1466
DELISTED
Cano Health, Inc.
CANO
$2.86K ﹤0.01%
105
– –
AAP icon
1467
Advance Auto Parts
AAP
$3.35B
– –
-2,930
Closed -$208K
ACT icon
1468
Enact Holdings
ACT
$6.61B
– –
-43,896
Closed -$1.13M
ALLO icon
1469
Allogene Therapeutics
ALLO
$649M
– –
-53,192
Closed -$264K
ALRM icon
1470
Alarm.com
ALRM
$2.71B
– –
-19,579
Closed -$998K
AMH icon
1471
American Homes 4 Rent
AMH
$12B
– –
-64,124
Closed -$2.29M
APLS
1472
DELISTED
Apellis Pharmaceuticals
APLS
– –
-10,007
Closed -$893K
ARCO icon
1473
Arcos Dorados Holdings
ARCO
$1.72B
– –
-29,300
Closed -$300K
ARRY icon
1474
Array Technologies
ARRY
$803M
– –
-90,119
Closed -$2.01M
ARWR icon
1475
Arrowhead Research
ARWR
$11.9B
– –
-6,419
Closed -$226K
57 58
59
60 61

Similar funds

Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Mackenzie Financial's Q3 2023 Portfolio in Review

As of Q3 2023, Mackenzie Financial held 1,631 positions worth $59.5B, down 9.8% from $65.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mackenzie Financial withdrew a net $1.84B in Q3 2023, closing 165 positions and reducing 587 holdings. Its most notable exit was Black Knight, Inc. Common Stock, an estimated $84.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, Mackenzie Financial opened a new position in Axonics, Inc. Common Stock worth $68.5M.

  • Mackenzie Financial's largest Q3 2023 buy was Axonics, Inc. Common Stock: 1,239,133 shares worth $68.5M.
  • Mackenzie Financial added most to Thomson Reuters in Q3 2023, an estimated $119M increase.
  • Mackenzie Financial's biggest Q3 2023 reduction was Danaher, cutting an estimated $313M.
  • Mackenzie Financial fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $84.9M.
  • Mackenzie Financial's ten largest holdings make up 22% of its $59.5B portfolio in Q3 2023.
  • Mackenzie Financial opened 128 new positions and closed 165 in Q3 2023.
  • Mackenzie Financial's portfolio value fell 9.8% quarter-over-quarter to $59.5B.

Based on Mackenzie Financial's 13F filing for Q3 2023, filed 25 Oct 2023.